Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
Public ClinicalTrials.gov record NCT02434133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The investigators proposed study is the first of its kind. The investigators will measure measles, mumps, rubella, tetanus, diphtheria and pertussis antibodies in patients on the current IBD treatment modalities and compare the vaccine antibody concentrations and correlate them with time since immunization.
Study identification
- NCT ID
- NCT02434133
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2015
- Primary completion
- Mar 31, 2016
- Completion
- Nov 30, 2017
- Last update posted
- Nov 26, 2018
2015 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Wisconsin Hospital & Clinics | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Inflammatory Bowel Disease (IBD) trials
Other public records listing Inflammatory Bowel Disease (IBD). Sorted by last update posted; newest first. Not a recommendation.
- NCT07237516: Zymfentra (Infliximab-dyyb) REal World Cohort STudy Recruiting
- NCT07676136: A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients Not yet recruiting
- NCT07590518: VR Therapies for IBD Not yet recruiting
- NCT07221890: A Trial of Academic Detailing to Promote Prescribing of Biosimilars Active, not recruiting
- NCT07123350: Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease Active, not recruiting
- NCT07368972: Study of DISC-0974-201 in Participants With IBD and Anemia Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02434133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 26, 2018 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02434133 live on ClinicalTrials.gov.